Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 12.39
-1.04 %
$ 1.13 B
Market Cap
-9.68
P/E
MYGN - CAPITAL EXPENDITURES
Capital Expenditures MYGN - Myriad Genetics, Inc.
-73.3 M
LAST VALUE
-101.80%
2 YEAR CAGR
-53.50%
5 YEAR CAGR
-17.78%
10 YEAR CAGR